Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 23.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
23.02.Seafire AB: Seafire year-end report 2023: Weak margin, but strong cash flow towards the year-end27Revenue increased by 8% to SEK 227 million (210), while operating profit, adjusted EBITA, amounted to SEK 3 million (9) in Q4. A disappointing end to the year, primarily as a result of negative organic...
► Artikel lesen
23.02.Lundin Gold Inc.: Lundin Gold Reports Fourth Quarter and Full Year Results3Production and Cost Performance Meets Upgraded Guidance VANCOUVER, BC, Feb. 22, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased...
► Artikel lesen
23.02.Abliva AB: Abliva AB Year-End Report January - December 20234140 Patients Enrolled in Wave 1 of the FALCON Study | Fast Track Designation for KL1333 | Orphan Drug Designation for NV354 in both US and Europe 2023 SummaryImportant events during 2023KL1333The first...
► Artikel lesen
23.02.SynAct Pharma AB: SynAct Pharma today publishes the fourth quarter and annual results of 202349"We have excellent opportunities before us, and we remain focused on delivering patient, company and shareholder value," said Torbjørn Bjerke, CEO. October - December 2023The Group's net sales amounted...
► Artikel lesen
23.02.Kancera AB: Interim Report Fourth Quarter 2023, October 1 - December 31126The period in brief - financial summary for the fourth quarterNet sales amounted to SEK 0 million (SEK 0).R&D expenses amounted to SEK 17,1 million (SEK 11,6 million).Operating income amounted to SEK...
► Artikel lesen
23.02.Edoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business Combination317Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting")...
► Artikel lesen
23.02.Coherus BioSciences, Inc.: Coherus BioSciences Announces New Employment Inducement Grants365REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that effective February 20, 2024, the compensation committee...
► Artikel lesen
23.02.Adamas One Corp.: Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)319SCOTTSDALE, Ariz., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) ("Adamas One," "Adamas" or the "Company"), The Original Lab-Grown Diamond Company, a high-tech company that leverages...
► Artikel lesen
23.02.NeuroOne Medical Technologies Corp: NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)283EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical...
► Artikel lesen
23.02.MoneyHero Limited: MoneyHero Group Appoints Rohith Murthy Chief Executive Officer344SINGAPORE, Feb. 23, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) ("MoneyHero" or the "Company"), a market-leading personal finance aggregation and comparison platform in Greater Southeast...
► Artikel lesen
23.02.Celularity, Inc.: Celularity Announces 1-for-10 Reverse Stock Split349FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) ("Celularity"), a biotechnology company developing allogeneic cell therapies and advanced biomaterial products...
► Artikel lesen
23.02.Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)198NOVATO, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
► Artikel lesen
23.02.TELA Bio, Inc.: TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)222MALVERN, Pa., Feb. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
► Artikel lesen
23.02.Mesa Air Group, Inc.: Mesa Air Group Discloses Notice from Nasdaq206PHOENIX, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) ("Mesa" or the "Company") today announced that it received a notice ("Notice") on February 21, 2024 from the Listing...
► Artikel lesen
23.02.Looking Glass Labs Ltd: Looking Glass Labs Welcomes Natasha Ingram as New CEO to Spearhead Innovative Open Metaverse Initiatives923VANCOUVER, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Looking Glass Labs Ltd. ("LGL" or the "Company") (Cboe Canada: NFTX) (OTC: LGSLF) (FRA: H1N) a leading company in the Open Metaverse...
► Artikel lesen
23.02.DT Cloud Acquisition Corporation Announces Closing of $69 Million Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option142New York, New York, Feb. 23, 2024 (GLOBE NEWSWIRE) -- DT Cloud Acquisition Corporation (NASDAQ: DYCQU, the "Company") announced today that it closed its initial public offering ("IPO") of 6,900,000...
► Artikel lesen
23.02.Wetouch Technology Inc. Announces Closing of $10.8 Million Public Offering of Common Stock355Meishan, Sichuan, China, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Wetouch Technology Inc. (Nasdaq: WETH) ("Wetouch" or the "Company"), a Nevada company, through its wholly-owned subsidiary, engaged in the...
► Artikel lesen
23.02.WestBond Enterprises Corporation: WestBond reports Financial Results for the Quarter ended December 31, 2023108DELTA, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) -- WestBond Enterprises Corporation (TSX-V: WBE) has posted a loss of $51,828 (-$0.001 per share) for the three months ended December 31, 2023...
► Artikel lesen
23.02.Hypefactors A/S: Minutes from Extraordinary General Meeting255Copenhagen, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Announcement no. 2-2024 On 23 February 2024, at 16:00, an Extraordinary General Meeting of Hypefactors A/S was conducted at the company's address, with...
► Artikel lesen
23.02.Scanfil Oyj: All-time high operating profit and cash flow23023.2.2024 08:00:03 EET | Scanfil Oyj | Financial Statement Release Scanfil plc Financial statement release 23 February 2024 at 8.00 a.m. EETScanfil plc: All-time high operating profit and...
► Artikel lesen
Seite:  Weiter >>